Population
Human coronary artery vascular smooth muscle cells (VSMCs)
Design
Preclinical
Authors
Loading...
KCa3.1 blockade may limit VSMC proliferation in vitro; leaves open therapeutic targeting in atherosclerosis pending in vivo studies.
KCa3.1 regulates vascular smooth muscle cell proliferation via calcium-dependent signaling, highlighting its potential as a therapeutic target for atherosclerosis.
Bi et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: